American Association for the Study of Liver Diseases and the International Liver Transplantation Society Course (AASLD/ILTS), Part 3: Expanding the Donor Pool Through Perfusion Technology (Ticketed)
Nov
08
2025
Convention Center: Room 202, Level 2
11:00 AM
- 12:30 PM
Ticketed Event
World Class Speakers
Description
Explore the innovative role of machine perfusion technologies in expanding the liver donor pool. Presenters highlight the latest in preservation platforms, therapeutic interventions during perfusion, and the use of viability markers to optimize graft success.
Journey Maps
Presentations
11:00 AM
- 11:15 AM
Oct
10
2026
Convention Center - Room 202, Level 2
What Is the Current Menu for Preservation of Liver Grafts?
James V Guarrera, MD, MD
, Presenter
Transplant
11:15 AM
- 11:30 AM
Oct
10
2026
Convention Center - Room 202, Level 2
What Does the Future of Liver Viability Markers Look Like?
Robert Porte, MD, PhD
, Presenter
Transplant
11:30 AM
- 11:45 AM
Oct
10
2026
Convention Center - Room 202, Level 2
An Update on Organ Treatment or Rehabilitation With Perfusion Technology
Markus Selzner
, Presenter
Transplant
11:45 AM
- 12:00 PM
Oct
10
2026
Convention Center - Room 202, Level 2
Liver Perfusion and Unintended Consequences
David C Mulligan, MD, FACS, FAASLD, FAST
, Presenter
Transplant
12:00 PM
- 12:30 PM
Oct
10
2026
Convention Center - Room 202, Level 2
Q&A and Panel Discussion
Hyosun Han, MD, FAASLD
, Moderator
Transplant
Objectives
- Identify recent developments regarding the role of machine perfusion in expansion of the donor pool.
- Review current preservation platforms.
- Explain the current status of intervention and treatment of liver grafts during perfusion.
- Recognize current markers of viability of the perfused grafts.
Chair
Nazia Selzner, MD, PhD
University of Toronto
Chair
Ryutaro P Hirose, MD
University of Washington Medical Center